• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    2/14/22 7:07:25 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials
    Get the next $SENS alert in real time by email
    SC 13G/A 1 tm226138d20_sc13ga.htm SCHEDULE 13G/A

     

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    (RULE 13d - 102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2

     

    (Amendment No. 5)*

     

    Senseonics Holdings, Inc.

    (Name of Issuer)

     

    Common Stock, $0.001 par value per share

    (Title of Class of Securities)

     

    81727U105

    (CUSIP Number)

     

    December 31, 2021

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    x       Rule 13d-1(b)

     

    ¨       Rule 13d-1(c)

     

    ¨       Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    (Page 1 of 5 Pages)

     

     

     

     

     

     

    Page 2 of 5

     

    CUSIP No. 81727U105

     

    1

    NAME OF REPORTING PERSON

     

    Gilder, Gagnon, Howe & Co. LLC

     

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)     ¨
        (b)     ¨
         
    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    0

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    0

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

     

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES      ¨

     

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0%

     

    12

    TYPE OF REPORTING PERSON

     

    BD

     

           

     

     

     

     

    Page 3 of 5

     

    ITEM 1(a).Name of Issuer:

     

    Senseonics Holdings, Inc.

     

    Item 1(b).Address of Issuer's Principal Executive Offices:

     

    20451 Seneca Meadows Parkway

    Germantown, MD 20876

     

    Item 2(a).Name of Persons Filing:

     

    Gilder, Gagnon, Howe & Co. LLC

     

    Item 2(b).Address of Principal Business Office or, if None, Residence:

     

    475 10th Avenue

    New York, NY 10018

     

    Item 2(c).Citizenship:

     

    New York

     

    Item 2(d).Title of Class of Securities

     

    Common Stock

     

    Item 2(e).CUSIP Number:

     

    81727U105

     

    ITEM 3.IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) x Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
           
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) ¨ Insurance company defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8).
           
      (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
           
      (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
           
      (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
           
      (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
           
      (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3);
           
      (j) ¨ A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J)
           
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

     

     

     

    Page 4 of 5

     

    Item 4.Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a)Amount beneficially owned: 0

     

    (b)Percent of class: 0%

     

    (c)Number of shares of Common Stock as to which such person has:

     

    (i)Sole power to vote or direct the vote: 0

     

    (ii)Shared power to vote or direct the vote: 0

     

    (iii)Sole power to dispose or direct the disposition: 0

     

    (iv)Shared power to dispose or direct the disposition: 0

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     

    Not applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.Certification.

     

    By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11.

     

     

     

     

    Page 5 of 5

     

    SIGNATURES

     

    After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

     

    Dated: February 14, 2022

     

     

      GILDER, GAGNON, HOWE & CO. LLC
         
         
      By: /s/ Laura Esposito
      Name: Laura Esposito
      Title: Chief Compliance Officer

     

     

    Get the next $SENS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SENS

    DatePrice TargetRatingAnalyst
    4/10/2025$2.00Outperform
    Mizuho
    7/19/2023$0.50Underperform
    Jefferies
    8/19/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SENS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

      GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the pricing of an underwritten public offering of 100,000,000 shares of common stock at a price to the public of $0.50 per share of common stock. The gross proceeds to Senseonics from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $50,000,000. In addition, Senseonics granted the underwriters a 30-day option to purchase up to an additional 15,000,

      5/15/25 11:12:42 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

      GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell shares of its common stock. In connection with the proposed offering, Senseonics also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of shares of common stock offered in the public offering. All of the shares of common stock to be sold in the proposed

      5/15/25 4:05:39 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Reports First Quarter Financial Results

      Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.3 million in the first quarter of 2025CMS upda

      5/8/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

      SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

      2/13/24 5:13:59 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

      SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

      7/7/23 4:35:55 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G filed by Senseonics Holdings Inc.

      SC 13G - Senseonics Holdings, Inc. (0001616543) (Subject)

      4/10/23 5:10:45 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    SEC Filings

    See more

    $SENS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Senseonics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Senseonics Holdings, Inc. (0001616543) (Filer)

      5/16/25 5:20:57 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form 424B5 filed by Senseonics Holdings Inc.

      424B5 - Senseonics Holdings, Inc. (0001616543) (Filer)

      5/16/25 4:22:32 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form 424B5 filed by Senseonics Holdings Inc.

      424B5 - Senseonics Holdings, Inc. (0001616543) (Filer)

      5/15/25 5:20:36 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Mizuho initiated coverage on Senseonics with a new price target

      Mizuho initiated coverage of Senseonics with a rating of Outperform and set a new price target of $2.00

      4/10/25 12:43:40 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Jefferies initiated coverage on Senseonics with a new price target

      Jefferies initiated coverage of Senseonics with a rating of Underperform and set a new price target of $0.50

      7/19/23 7:24:20 AM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • HC Wainwright & Co. initiated coverage on Senseonics Holdings with a new price target

      HC Wainwright & Co. initiated coverage of Senseonics Holdings with a rating of Buy and set a new price target of $6.00

      8/19/21 6:19:58 AM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Fiorentino Edward was granted 21,243 shares, increasing direct ownership by 2% to 1,204,041 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      4/3/25 4:30:45 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Steven Edelman was granted 19,363 shares, increasing direct ownership by 2% to 1,124,567 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      4/3/25 4:30:38 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Prince Douglas S was granted 12,219 shares, increasing direct ownership by 1% to 959,152 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      4/3/25 4:30:38 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Roeder Douglas A bought $37,500 worth of shares (75,000 units at $0.50), increasing direct ownership by 5% to 1,463,087 units (SEC Form 4)

      4/A - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/20/24 5:37:53 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Roeder Douglas A bought $135,500 worth of shares (325,000 units at $0.42), increasing direct ownership by 30% to 1,413,087 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/16/24 4:21:25 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Sullivan Frederick T. bought $47,475 worth of shares (124,933 units at $0.38), increasing direct ownership by 5% to 2,478,844 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/12/24 7:04:14 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Financials

    Live finance-specific insights

    See more
    • Senseonics Holdings, Inc. Reports First Quarter Financial Results

      Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.3 million in the first quarter of 2025CMS upda

      5/8/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

      GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Management will hold a conference call to review the Company's first quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigat

      4/29/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

      Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately 6,000 global patients GERMANTOWN, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the fourth quarter ended December 31, 2024. Recent Highlights & Accomplishments: Eversense® 365 approved and launched in the U.S. during 2024 as an integrated contin

      3/3/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials